Abstracts deadline Friday 24 April 2026! Submit now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
Thank you for the interest in on-demand registrations for APLAR 2025. On-demand registration is now closed. We appreciate your enthusiasm and support. Stay tuned for updates on future congresses and opportunities to engage with the APLAR community.
Cross-post from Fukuoka Convention & Visitors Bureau LinkedIn News Post: Read it here APLAR, or the Asia-Pacific League of Associations for Rheumatology, held their 27th annual congress in Fukuoka from September 3rd until September 7th. The event saw an incredible turn-out with over 2,500 participants from 68 countries and 1,900 abstract submissions! This makes it the largest APLAR Congress yet! Held in the Fukuoka International Congress Center, this was an event that brought together researchers from all over the region-
Missed out on APLAR 2025? Check out what you missed here!
As an APLAR 2025 attendee, you can re-watch all streamed content for 12 months! Watch the sessions you missed, or revisit over 250 expert presentations from the comfort of your home or office through our app. You can still sign up and have 12-month access to the on-demand sessions. See the On-Demand Registration Portal for more information Keep learning from Asia-Pacific’s leading rheumatology experts!
We are excited to announce the release of new videos on the APLAR Congress website. These videos provide updates on the upcoming congress and initiatives from the APLAR cohort. The videos feature messages from various members of the APLAR community, including Prof Tsutomu Takeuchi, President, APLAR, and many others. Each video offers unique insights and updates about the congress, making them a must-watch for anyone interested in the event. The 27th Asia-Pacific League of Associations for Rheumatology Congress is set
Nestled on the northern shore of Kyushu, Fukuoka is a vibrant fusion of tradition and innovation – an ideal destination for global travelers and congress delegates alike. As the host city for APLAR 2025, Fukuoka offers more than just a venue; it promises an immersive cultural experience.
The early bird registration deadline for APLAR 2025 has been extended until 20 May 2025 — don’t miss your chance to be part of the region’s premier rheumatology event. Join us for five days of world-class speakers, interactive sessions, and unmissable networking opportunities.
We have noticed fraudulent activity from unsupported accommodation providers contacting delegates and speakers to book your accommodation at APLAR 2022, 2023, 2024 and 2025. These companies are not supported by APLAR or the congress organisers. If you have been contacted directly to book accommodation, please do not engage, or proceed with booking your hotel. All accommodation bookings can be made with the APLAR congress secretariat via info@aplarcongress.com or directly through the website: https://aplarcongress.com/accommodation/ Please report any suspicious accommodation communications to info@aplarcongress.com
Shifting the Trajectory: Understanding the Implications of an early subcutaneous application of Methotrexate Early use of subcutaneous methotrexate MTX can shift the treatment trajectory by improving disease control, reducing side effects, and delaying other therapies. It is particularly valuable for patients with oral intolerance or inadequate response to oral MTX. Therefore subcutaneous MTX plays an increasingly important role in the treatment of rheumatoid arthritis (RA) because it offers clinical advantages compared to oral use: Greater Clinical EfficacyStudies show that patients
From Evidence to Confidence: Real-world Clinical Experience with Biosimilars in Europe Objectives: Norway was one of the first countries to implement widespread biosimilar use, led by pioneering research such as the NOR-SWITCH study. This session features Professor Tore K. Kvien, who will share his extensive, decade-long experience with biosimilars in clinical practice. The discussion will move beyond theoretical benefits to focus on long-term real-world data, the evolution of clinician and patient perspectives, and the practical “Experience” that has shaped current
Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
